Small Unruptured Intracranial Aneurysms Grow Slowly

Share this content:
Small Unruptured Intracranial Aneurysms Grow Slowly
Small Unruptured Intracranial Aneurysms Grow Slowly

TUESDAY, June 6, 2017 (HealthDay News) -- Small unruptured intracranial aneurysms (UIAs) have low growth and rupture rates, according to a review published online June 6 in the Annals of Internal Medicine.

Ajay Malhotra, M.D., from the Yale School of Medicine and Yale University in New Haven, Conn., and colleagues conducted a systematic literature review and summarized evidence relating to the growth and rupture risk of UIAs 7 mm and smaller and rupture risks for very-small and small aneurysms (≤3 and ≤5 mm, respectively). Five, 10, and eight studies described the rate of growth of aneurysms that were ≤3 mm, ≤5 mm, and ≤7 mm, respectively, while rupture rates were reported in seven, 11, and 13 studies, respectively.

The researchers found that in all but one study, the annualized growth rate was less than 3 percent for all three size categories. For the three size categories, the annualized rupture rate was 0, <0.5, and <1 percent respectively. For growth rates and rupture rates, the strength of evidence was very low and of a low quality, respectively.

"Poor-quality evidence suggests that small UIAs have low growth and rupture rates and very small UIAs have little or no risk for rupture," the authors write.

One author disclosed financial ties to Philips Healthcare.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »